In this study, we evaluated the risk of hemoglobin decline and bilirubin increase within 14 days after low‐dose aspirin in patients with different G6PD statuses and further investigated its association with functional outcomes at 3 months after stroke, to clarify the safety of aspirin use in those with G6PD deficiency. This evidence concerns the gene G6PD and Stroke.